首页> 外文期刊>British journal of ophthalmology >Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa
【24h】

Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa

机译:膀胱藻水肿,脑膜炎膜和白内障在视网膜炎中的患病率

获取原文
获取原文并翻译 | 示例
       

摘要

Background/Aims To report the prevalence of treatable complications (cystoid macular oedema, CME; epiretinal membrane, ERM and cataract) in patients with retinitis pigmentosa (RP). Methods Consecutive patients with RP attending a tertiary eye clinic in 2012. Spectral domain-optical coherence tomography was used to determine presence of CME and ERM. Clinic records were reviewed to identify cataract and pseudophakia. Multivariable analyses adjusted for age, gender and other confounders. Results Data are presented for 338 eyes from 169 patients. CME was present in 58.6% of patients and 50.9% of eyes and was bilateral in 73.7%. ERM, cataract and pseudophakia were present in 22.8%, 23.4% and 11.2% eyes, respectively. In multivariable analyses, CME was associated with younger age (OR 0.81, 95% CI 0.67 to 0.98) but not with gender. Patients with ERM and cataract/pseudophakia were less likely to also have CME (OR 0.19, 95% CI 0.09 to 0.40 and OR 0.37, 95% CI 0.16 to 0.84, respectively). CME was most prevalent in patients with autosomal-dominant inheritance (71.4%), followed by autosomal recessive/sporadic inheritance (58.9%) and least likely in persons with X linked inheritance (12.5%, p<0.001). Conclusions The prevalence of treatable RP complications is high and suggests it may be clinically beneficial to screen patients with RP to identify those who may benefit from current or future interventions.
机译:背景/旨在报告治疗并发症的患病率(Cystoid Mathume水肿,CME; emiretinal膜,ERM和白内障),患者患有视网膜炎粒子炎(RP)。方法在2012年连续rp患者参加三级眼诊所。光谱畴 - 光学相干断层扫描用于确定CME和ERM的存在。审查临床记录以识别白内障和假性纲。多变量分析调整年龄,性别和其他混乱。结果数据从169名患者提供338只眼睛。 CME占58.6%的患者和50.9%的眼睛,双边是73.7%。 ERM,白内障和假脂磷分别以22.8%,23.4%和11.2%的眼睛存在。在多变量分析中,CME与较小的年龄(或0.81,95%CI 0.67至0.98)相关,但不是性别。患有ERM和白内障/假性薄皮的患者的可能性也不太可能具有CME(或0.19,95%CI 0.09至0.40和0.37,95%CI 0.16至0.84)。 CME在常染色体显性遗传(71.4%)患者中最普遍的,其次是常染色体隐性/散发性遗传(58.9%),最少有X链接遗传的人(12.5%,P <0.001)。结论可治疗的RP并发症的患病率高,表明它可能是临床上有利于筛选RP患者,以确定可能受益于当前或未来干预的人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号